BioCardia, Inc. (BCDA) Total liabilities 2016–2025
BioCardia, Inc. (BCDA) total liabilities at each fiscal year-end, per SEC filings.
$2.5MFY2025 · since FY2016: $1.5M → $2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5M | -12.8% |
| FY2024 | $2.9M | -37.1% |
| FY2023 | $4.6M | -6.3% |
| FY2022 | $4.9M | -8.3% |
| FY2021 | $5.3M | +25.8% |
| FY2020 | $4.2M | -20.0% |
| FY2019 | $5.3M | +102.2% |
| FY2018 | $2.6M | +8.8% |
| FY2017 | $2.4M | +60.9% |
| FY2016 | $1.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BCDA financial trends
BCDA RevenueBCDA Net incomeBCDA Net marginBCDA Gross profitBCDA Gross marginBCDA Operating incomeBCDA Operating marginBCDA Operating cash flowBCDA Free cash flowBCDA Capital expendituresBCDA Return on equityBCDA Stock buybacksBCDA Dividends paidBCDA Total assetsBCDA Shareholders’ equityBCDA overview →